Matinas BioPharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $-1,096 |
Gross Profit | -241 | -240 | -1,336 |
EBITDA | -5,598 | -5,662 | -5,704 |
EBIT | -5,839 | -5,902 | -5,944 |
Net Income | -5,719 | -5,824 | -5,314 |
Net Change In Cash | 0 | 0 | -1,096 |
Free Cash Flow | -3,106 | -5,769 | -4,579 |
Cash | 4,216 | 1,121 | 4,837 |
Basic Shares | 4,987 | 4,347 | 4,345 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,096 | $3,188 | $33 | $158 |
Gross Profit | -13,393 | -13,490 | -748 | -14,200 |
EBITDA | -22,825 | -24,234 | -24,455 | -23,916 |
EBIT | -23,766 | -25,132 | -25,236 | -24,691 |
Net Income | -22,942 | -13,015 | -21,173 | -20,598 |
Net Change In Cash | 1,096 | 3,188 | 33 | 158 |
Cost of Revenue | -14,200 | 8,511 | -9,987 | |
Free Cash Flow | -15,496 | -20,048 | -15,483 | -17,373 |
Cash | 4,787 | 6,830 | 21,029 | 12,432 |
Basic Shares | 4,345 | 4,336 | 4,203 | 3,937 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.85 |
2024-06-30 | -$0.02 |
2024-03-31 | -$0.03 |
2023-12-31 | -$0.02 |
